Effect of Deferiprone versus Deferiprone with Deferasirox in Iron Chelation Therapy of Thalassemia Children
Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 9
Abstract
Background: Thalassemia is an autosomal recessive hemoglobin disorder requiring life-long blood transfusion causing iron overload. Combination therapy of oral iron chelators: Deferiprone (DFP) with Deferasirox (DFX) is an efficacious and safe modality to reduce serum ferritin in multi-transfused thalassemic children. This study was carried out to evaluate the effect of Deferiprone versus Deferiprone with Deferasirox in iron chelation therapy of transfusion dependent thalassemia children. Methodology: A cross sectional observational study was done in Pediatric Hematology and Oncology, Dhaka Medical College Hospital and Bangladesh Thalassemia Hospital in Dhaka from January to June 2018. Children with transfusion dependent β-thalassemia major and E-β-thalassemia having serum ferritin level >1000 ng/ml between 3 to 12 years of age were studied. Results: Demographic profile of 60 cases demonstrated that there are no significant differences in age, sex and weight between DFP-monotherapy and DFP-DFX-combination groups. Initial mean serum ferritin level was 3397.48±774.48 ng/ml in DFP-monotherapy group and 3413.70±1114.05ng/ml in DFP-DFX combination group. After treatment mean serum ferritin level at 6th month was 2730.63±839.91 ng/ml in DFP-monotherapy group and 1654.20±934.90 ng/ml in DFP-DFX-combination group which shows rapid reduction of serum ferritin level in DFP-DFX-combination group. Mean dose of drugs was 72.59(±3.76) mg/kg/ day of DFP in monotherapy group and 68.68(±4.84) mg/kg/ day of DFP and 27.98(±2.13) mg/kg/ day of DFX in combination group. 12 (40.0%) patients had arthralgia in DFP-monotherapy group and 5(16.7%) patients had vomiting in DFP-DFX-combination group. No abnormalities seen in liver and renal function tests. Conclusion: Deferiprone alone is capable in significant excretion of iron from the body in transfusion dependent thalassemia major patients. But combination therapy with Deferiprone and Deferasirox is more significantly effective in iron chelation and drug induced related complications.
Authors and Affiliations
Syeda Jarka Jahir
Keywords
Related Articles
- EP ID EP514962
- DOI -
- Views 59
- Downloads 0
Diagnostic Accuracy of Ultrasound in Malignant Testicular Swelling & Its Management-A Study of 34 Cases
Testicular swelling is a lump or a growth (mass) involving the genitalia is a common presentation in outdoor patients ranging from young to old. Occur in one or both the testicles. Proper diagnosis can prevent unnecessar...
Prospective Comparative Analysis of Platelets Rich Plasma vs Steroid in Tennis Elbow at Tertiary Heath Care Center- Index Medical College, Indore
Introduction: This study is to compare results of inj steroid and inj PRP in tennis elbow condition locally. People that requires repetitive supinaton & pronation of forearm with elbow in near full extension are more pre...
A Comparative Study of T-tube versus Ante grade Stenting of CBD after Open CBD Exploration for Choledocholithiasis
Background: CBD stones once confirmed have to be extracted in order to prevent the complications related to them. Conventionally T-tube is used for decompression of CBD after open choledocholithotomy which has its own sh...
Evaluation of Adherence, Knowledge, and Practices towards the Therapy in Patients of Chronic Kidney Diseaseq
Objective: Chronic kidney disease (CKD) is a prolonged illness with co-morbidities. These patients have to take a large number of pills per day. Hence, this study evaluates the extent of medication adherence and study fa...
A Cross Sectional Study Showing Association of Serum Uric Acid in PreDiabetic and Diabetic Indian Population
Background: Diabetes is a huge burden worldwide and India is only second to China in prevalence of Diabetes. Recent studies showed that the prevalence of Diabetes and Pre-diabetes (IGT) is rapidly increasing, especially...